Alvotech (ALVO) Net Equity Issued and Repurchased (2023 - 2025)

Alvotech (ALVO) posted Net Equity Issued and Repurchased of -$82.4 million for Q3 2025, down 48.28% on a QoQ basis from -$55.6 million in Q2 2025, and up 45.18% year-over-year from -$56.8 million in Q3 2024.

Alvotech (ALVO) Net Equity Issued and Repurchased (2023 - 2025) Analysis & Trends

Alvotech's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at -$82.4 million for Q3 2025.

  • Quarterly Net Equity Issued and Repurchased rose 45.18% year-over-year to -$82.4 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $150.5 million (up 9.85% YoY) and the FY2023 annual result came in at $136.9 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was -$82.4 million for Q3 2025 at Alvotech, down from -$55.6 million in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $150.5 million in Q4 2024 and bottomed at -$150.3 million in Q3 2024.
  • A 3-year average of $42.4 million and a median of $74.6 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased surged 620200.0% — and 2025, when it plunged 548.06%.
  • Alvotech's Net Equity Issued and Repurchased stood at $136.9 million in 2023, then grew by 9.92% to $150.5 million in 2024, then tumbled by 154.77% to -$82.4 million in 2025.
  • Business Quant data shows ALVO's Net Equity Issued and Repurchased at -$82.4 million in Q3 2025, -$55.6 million in Q2 2025, and $138.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 500,000.00
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -82.40 Mn
Sep 30, 2025 -82.40 Mn
Jun 30, 2025 -55.57 Mn
Jun 30, 2025 -55.57 Mn
Mar 31, 2025 138.05 Mn
Mar 31, 2025 138.05 Mn
Dec 31, 2024 150.45 Mn
Dec 31, 2024 150.45 Mn
Sep 30, 2024 -150.30 Mn
Sep 30, 2024 -150.30 Mn
Jun 30, 2024 12.40 Mn
Jun 30, 2024 12.40 Mn
Mar 31, 2024 138.05 Mn
Mar 31, 2024 138.05 Mn
Dec 31, 2023 136.88 Mn
Dec 31, 2023 136.88 Mn
Jun 30, 2023 -2,000.00
Jun 30, 2023 -2,000.00
Mar 31, 2023 136.88 Mn
Mar 31, 2023 136.88 Mn